AU2545397A - Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives - Google Patents
Aryloxy- and arylthio- fused pyridines and pyrimidines and derivativesInfo
- Publication number
- AU2545397A AU2545397A AU25453/97A AU2545397A AU2545397A AU 2545397 A AU2545397 A AU 2545397A AU 25453/97 A AU25453/97 A AU 25453/97A AU 2545397 A AU2545397 A AU 2545397A AU 2545397 A AU2545397 A AU 2545397A
- Authority
- AU
- Australia
- Prior art keywords
- pyrimidines
- arylthio
- aryloxy
- derivatives
- fused pyridines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1409096P | 1996-03-26 | 1996-03-26 | |
US60/014090 | 1996-03-26 | ||
US64661196A | 1996-05-08 | 1996-05-08 | |
US08/646611 | 1996-05-08 | ||
PCT/US1997/004828 WO1997035846A1 (en) | 1996-03-26 | 1997-03-25 | Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2545397A true AU2545397A (en) | 1997-10-17 |
AU725254B2 AU725254B2 (en) | 2000-10-12 |
Family
ID=26685647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25453/97A Ceased AU725254B2 (en) | 1996-03-26 | 1997-03-25 | Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0901476A4 (en) |
JP (1) | JP2000507552A (en) |
AU (1) | AU725254B2 (en) |
CA (1) | CA2249598A1 (en) |
NZ (1) | NZ331647A (en) |
WO (1) | WO1997035846A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19653646A1 (en) * | 1996-12-20 | 1998-06-25 | Hoechst Ag | Substituted purine derivatives, processes for their preparation, agents containing them and their use |
IL143105A0 (en) | 1998-11-12 | 2002-04-21 | Neurocrine Biosciences Inc | Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same |
AU755552B2 (en) | 1998-11-12 | 2002-12-12 | Neurocrine Biosciences, Inc. | CRF receptor antagonists and methods relating thereto |
US6432989B1 (en) | 1999-08-27 | 2002-08-13 | Pfizer Inc | Use of CRF antagonists to treat circadian rhythm disorders |
CA2419626A1 (en) * | 2000-07-14 | 2002-01-24 | Rajagopal Bakthavatachalam | Imidazo¬1,2-a|pyrazines for the treatment of neurological disorders |
RS50863B (en) | 2001-03-13 | 2010-08-31 | Bristol-Myers Squibb Pharma Company | 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid- -3-yl)pyrazolo-/1,5-a/-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
PL366577A1 (en) | 2001-05-14 | 2005-02-07 | Bristol-Myers Squibb Pharma Company | Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
AU2002354575A1 (en) | 2001-07-12 | 2003-01-29 | Bristol-Myers Squibb Pharma Company | Tetrahydropurinones as corticotropin releasing factor |
WO2003006015A1 (en) | 2001-07-13 | 2003-01-23 | Bristol-Myers Squibb Pharma Company | Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
WO2003043637A1 (en) | 2001-11-20 | 2003-05-30 | Bristol-Myers Squibb Pharma Company | 3,7-dihydro-purine-2,6-dione derivatives as crf receptor ligands |
GB0219746D0 (en) | 2002-08-23 | 2002-10-02 | Inst Of Ex Botany Ascr | Azapurine derivatives |
KR20210061202A (en) * | 2019-11-19 | 2021-05-27 | 일동제약(주) | Benzonitrile-substituted Fused pyrimidine derivatives and their pharmaceutical use |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4076711A (en) * | 1976-04-05 | 1978-02-28 | Schering Corporation | Triazolo [4,5-d]-pyrimidines |
JPS56131587A (en) * | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | 7-substituted triazolopyrimidine derivative and its preparation |
JPS56131586A (en) * | 1980-03-18 | 1981-10-15 | Ss Pharmaceut Co Ltd | Triazolopyrimidine derivative and its preparation |
JPS5962595A (en) * | 1982-09-30 | 1984-04-10 | Ss Pharmaceut Co Ltd | 3,5,7-trisubstituted-triazolopyrimidine derivative and its preparation |
EP0141927B1 (en) * | 1983-08-18 | 1991-10-30 | Beecham Group Plc | Antiviral guanine derivatives |
DE3722802A1 (en) * | 1987-07-10 | 1989-01-19 | Hoechst Ag | 2-AMINO-8-AZA PURINS SUBSTITUTED IN 6 AND 9 POSITIONS, THEIR USE, MEDICINAL PRODUCTS CONTAINING THESE PURINES AND METHOD FOR THE PRODUCTION OF THE PURINS |
US4916224A (en) * | 1988-01-20 | 1990-04-10 | Regents Of The University Of Minnesota | Dideoxycarbocyclic nucleosides |
GB9011623D0 (en) * | 1990-05-24 | 1990-07-11 | Efamol Holdings | Synthesis of nucleotide and nucleoside derivatives |
NZ258690A (en) * | 1992-12-17 | 1997-01-29 | Pfizer | Pyrrolopyrimidines and pharmaceutical compositions containing such compounds; intermediate pyrrole compounds |
TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
WO1995010506A1 (en) * | 1993-10-12 | 1995-04-20 | The Du Pont Merck Pharmaceutical Company | 1n-alkyl-n-arylpyrimidinamines and derivatives thereof |
GB9400987D0 (en) * | 1994-01-19 | 1994-03-16 | Reese Colin B | Production of nucleoside analogues |
JP3291299B2 (en) * | 1994-06-06 | 2002-06-10 | ファイザー・インク | Substituted pyrazoles having corticotropin releasing factor (CRF) antagonist activity |
TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
KR100235277B1 (en) * | 1994-06-16 | 1999-12-15 | 디. 제이. 우드, 스피겔 알렌 제이 | Pyrazolo and pyrrolopyridines |
ES2200039T3 (en) * | 1995-12-08 | 2004-03-01 | Pfizer Inc. | HETEROCICLIC DERIVATIVES REPLACED AS CRF ANTAGONISTS. |
-
1997
- 1997-03-25 EP EP97916985A patent/EP0901476A4/en not_active Withdrawn
- 1997-03-25 WO PCT/US1997/004828 patent/WO1997035846A1/en not_active Application Discontinuation
- 1997-03-25 NZ NZ331647A patent/NZ331647A/en unknown
- 1997-03-25 JP JP9534562A patent/JP2000507552A/en active Pending
- 1997-03-25 AU AU25453/97A patent/AU725254B2/en not_active Ceased
- 1997-03-25 CA CA002249598A patent/CA2249598A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU725254B2 (en) | 2000-10-12 |
CA2249598A1 (en) | 1997-10-02 |
WO1997035846A1 (en) | 1997-10-02 |
JP2000507552A (en) | 2000-06-20 |
EP0901476A4 (en) | 2001-08-16 |
EP0901476A1 (en) | 1999-03-17 |
NZ331647A (en) | 2000-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL335258A1 (en) | Arylamine-condensed pyridines and pyrimidines | |
AU4383397A (en) | Hetaroyl derivatives | |
AU4554297A (en) | Hetaroyl derivatives | |
IL131521A0 (en) | Pyrimidine derivatives | |
AU2303097A (en) | Quinazoline derivatives | |
AU1252897A (en) | Substituted quinazoline derivatives | |
AU2897897A (en) | Aryl pyrimidine derivatives | |
AU3008297A (en) | Dihydropyrimidines and uses thereof | |
AU2844897A (en) | Bicyclic-fused pyridines | |
AU7687298A (en) | Dihydropyrimidines and uses thereof | |
AU1411499A (en) | Para-aminomethylaryl carboxamide derivatives | |
HK1026418A1 (en) | Novel pyrimidine derivatives and processes for the preparation thereof | |
ZA971896B (en) | Aryloxy-and arythio-fused pyridines and pyrimidines and derivatives | |
AU8885498A (en) | Triazine derivatives, their production and use | |
AU2464197A (en) | Triazine derivatives and their use | |
ZA972553B (en) | Aryloxy-and arylthio- substituted pyrimidines and triazines and derivatives thereof | |
AU2545397A (en) | Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives | |
AU1415099A (en) | 4-substituted-4-piperidine carboxamide derivatives | |
AU3486195A (en) | Pyrimidinone derivatives | |
AU9809698A (en) | Substituted pyrimidine and pyridine herbicides | |
AU1687699A (en) | Nitrogenous heterocyclic derivatives | |
AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
HK1025955A1 (en) | Novel pyrimidine derivative | |
AU1670297A (en) | Benzofuran-7-yluracil derivatives and herbicides | |
AU2448292A (en) | Pyrimidine derivative and weedkiller |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) | ||
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |